Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

404 trials

NCT07380295
Recruiting
Improving Workforce Participation and Well-Being in Individuals With Multiple Sclerosis - A Feasability Study
Not applicable · Sweden · 1 site
Registry update: 2 Feb 2026
NCT06455332
Recruiting
Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome
Not applicable · France · 1 site
Registry update: 24 Aug 2025
NCT06992115
Recruiting
A Study of the MIND Diet for Persons With Multiple Sclerosis
Not applicable · United States · 1 site
Registry update: 2 Oct 2026
NCT07168772
Recruiting
The Effect of a Probiotic Administration as an add-on Treatment in Multiple Sclerosis
Not applicable · Spain · 1 site
Registry update: 7 Aug 2026
NCT06782724
Recruiting
Psilocybin Therapy for Psychological Distress in Palliative Patients
Phase 2 · Czechia, Denmark, Netherlands, Portugal · 4 sites
Registry update: 8 May 2026
NCT06846281
Recruiting
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Phase 3 · Argentina, Australia, Belgium, Brazil, Canada, Switzerland, Czechia, Germany, Denmark, Spain, France, United Kingdom, Greece, Italy, Mexico, Portugal, Slovakia, United States, South Africa · 132 sites
Registry update: 26 Oct 2026
NCT06939166
Recruiting
Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases
Early phase 1 · China · 1 site
Registry update: 15 Dec 2025
2024-514549-12-00
Recruiting
The use of therapeutic monitoring of ocrelizumab serum concentrations for personalized pharmacotherapy of relapsing-remitting and primary progressive multiple sclerosis
Phase 4 · Czechia · 1 site
Registry update: 5 Sept 2025
NCT07111637
Recruiting
Artificial Intelligence-Assisted Magnetic Resonance Imaging for Quality, Efficiency and Equity in the National Health Service (NHS) Care of Multiple Sclerosis
Not applicable · United Kingdom · 1 site
Registry update: 12 Aug 2026
NCT06782490
Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Phase 2 · Australia, Canada, Czechia, Germany, Poland, Puerto Rico, United States · 61 sites
Registry update: 27 Oct 2026
NCT06426316
Recruiting
The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.
Not applicable · France · 1 site
Registry update: 20 Nov 2025
NCT06955832
Recruiting
Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI
Not applicable · Egypt · 3 sites
Registry update: 18 May 2025
NCT07116070
Recruiting
Sarcopenia and Related Factors in Patients With Multiple Sclerosis
Not applicable · 1 site
Registry update: 11 Aug 2025
NCT07087106
Recruiting
Glucose Consumption in MS Using [F-18]FDG-PET
Phase 4 · United States · 1 site
Registry update: 9 Jan 2026
NCT07087873
Recruiting
Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases
Not applicable · China · 1 site
Registry update: 28 Jul 2025
NCT06986278
Recruiting
tdCS Combined With Treadmill Training in Patients With Multiple Sclerosis
Not applicable · Spain · 2 sites
Registry update: 29 May 2025
NCT07202494
Recruiting
Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
Not applicable · France · 1 site
Registry update: 1 Oct 2025
NCT04634994
Recruiting
Assessment of Synaptic Density in MS
Early phase 1 · United States · 1 site
Registry update: 9 Jan 2026
NCT06680037
Recruiting
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Phase 1 · United States · 8 sites
Registry update: 27 Oct 2026
NCT06999434
Recruiting
Exploring the Utility of [18F]3F4AP for Demyelination Imaging
Phase 1 · United States · 1 site
Registry update: 9 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.